Market revenue in 2023 | USD 587.3 million |
Market revenue in 2030 | USD 2,473.4 million |
Growth rate | 22.8% (CAGR from 2023 to 2030) |
Largest segment | Software |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Hardware, Services |
Key market players worldwide | Siemens Healthineers AG ADR, Nano X Imaging Ltd Ordinary Shares, GE HealthCare Technologies Inc Common Stock, AliveCor, Riverain Technologies, Aidoc, NeuraSignal, Imagen Technologies, Digital Diagnostics, Vuno |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 40.25% in 2023. Horizon Databook has segmented the U.S. artificial intelligence in diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
In February 2019, Executive Order on Maintaining American Leadership in Artificial Intelligence was introduced by the government to reduce barriers in the use of AI technology, enhancing access to fully traceable, high-quality federal data while maintaining privacy, confidential protections, safety, & security with applicable laws & policies.
The AI powered medical imaging systems can produce scans to assist radiologists in identifying patterns & indicating treatments to patients affected by serious conditions. These systems can also help in coping with growing workloads.
In November 2019, the U.S.-based startup, Path AI, announced a strategic investment of USD 15 million from Merck Global Health Innovation Fund (Merck GHIF) and Bristol Myers Squibb to complete its USD 75 million Series B Funding investment, accelerating its growth in clinical development capabilities.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. artificial intelligence in diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. artificial intelligence in diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account